Appointee to head National Cancer Institute discusses research financing cuts John Niederhuber, a cosmetic surgeon whom President Bush on Tuesday appointed as National Malignancy Institute director, on Wednesday said that he hopes to find new non-toxic cancer medications but added that the agency likely will have to eliminate some programs because of budgetary issues, the New York Times reviews levitra online click here . The NIH spending budget doubled between 1998 and 2003, however the agency budget is becoming flat recently. Niederhuber said that he will use a collaborative procedure to recognize NCI programs to phase out. Nevertheless, Niederhuber said that he hopes to invest more in high-technology machines to find new cancer medicines and that he plans to support cancers centers at universities nationwide.
Represents around $1.2 billion in product sales. Apotex Corp has a strong product sales and marketing group which has positioned the company in the very best tier of generic pharmaceutical companies in the U.S. Market. We are excited to include this important, quality product inside our portfolio and to have the ability to offer it to your valued healthcare partners stated Jeff Watson, Chief Commercial Officer. The company will announce launch programs at a later time.. Apotex to advertise Hisamitsu’s Fentanyl Transdermal Program for chronic pain management Apotex Corp announced today that it has signed an exclusive distribution contract with Hisamitsu Pharmaceutical Firm of Japan.